Articles with public access mandates - Rachael RichardsonLearn more
Not available anywhere: 9
Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery
A Chang, H Eastwood, D Sly, D James, R Richardson, S O’Leary
Hearing research 255 (1-2), 67-72, 2009
Mandates: US National Institutes of Health
Atoh1 gene therapy in the cochlea for hair cell regeneration
RT Richardson, PJ Atkinson
Expert opinion on biological therapy 15 (3), 417-430, 2015
Mandates: US Department of Energy, National Health and Medical Research Council …
Novel drug delivery systems for inner ear protection and regeneration after hearing loss
RT Richardson, AK Wise, JK Andrew, SJ O'Leary
Expert opinion on drug delivery 5 (10), 1059-1076, 2008
Mandates: US National Institutes of Health
Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation
TM Connolly, H Eastwood, G Kel, H Lisnichuk, R Richardson, S O’Leary
Audiology and Neurotology 16 (3), 137-144, 2011
Mandates: US National Institutes of Health
Challenges for the application of optical stimulation in the cochlea for the study and treatment of hearing loss
RT Richardson, AC Thompson, AK Wise, K Needham
Expert Opinion on Biological Therapy 17 (2), 213-223, 2017
Mandates: National Health and Medical Research Council, Australia, Action on Hearing …
Treating hearing disorders with cell and gene therapy
LN Gillespie, RT Richardson, BA Nayagam, AK Wise
Journal of Neural Engineering 11 (6), 065001, 2014
Mandates: National Health and Medical Research Council, Australia, Action on Hearing …
Emerging therapies for human hearing loss
E Ajay, N Gunewardene, R Richardson
Expert opinion on biological therapy 22 (6), 689-705, 2022
Mandates: National Health and Medical Research Council, Australia
Pharmacokinetics and tissue distribution of neurotrophin 3 after intracochlear delivery
RT Richardson, QY Hu, F Shi, T Nguyen, JB Fallon, BO Flynn, AK Wise
Journal of Controlled Release 299, 53-63, 2019
Mandates: National Health and Medical Research Council, Australia
Timing is Everything: Stochastic Optogenetic Stimulation Reduces Adaptation in Retinal Ganglion Cells
WC Kwan, EK Brunton, JM Begeng, RT Richardson, MR Ibbotson, ...
2023 45th Annual International Conference of the IEEE Engineering in …, 2023
Mandates: Australian Research Council, National Health and Medical Research Council …
Available somewhere: 32
Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons
RT Richardson, AK Wise, BC Thompson, BO Flynn, PJ Atkinson, ...
Biomaterials 30 (13), 2614-2624, 2009
Mandates: US National Institutes of Health
Relations between cochlear histopathology and hearing loss in experimental cochlear implantation
SJ O'leary, P Monksfield, G Kel, T Connolly, MA Souter, A Chang, ...
Hearing Research 298, 27-35, 2013
Mandates: National Health and Medical Research Council, Australia
Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea
AK Wise, CR Hume, BO Flynn, YS Jeelall, CL Suhr, BE Sgro, SJ O'leary, ...
Molecular Therapy 18 (6), 1111-1122, 2010
Mandates: US National Institutes of Health
Hair cell regeneration after ATOH1 gene therapy in the cochlea of profoundly deaf adult guinea pigs
PJ Atkinson, AK Wise, BO Flynn, BA Nayagam, RT Richardson
PloS one 9 (7), e102077, 2014
Mandates: National Health and Medical Research Council, Australia, Action on Hearing …
Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea
H Eastwood, A Chang, G Kel, D Sly, R Richardson, SJ O’Leary
Hearing research 265 (1-2), 25-29, 2010
Mandates: US National Institutes of Health
New molecular therapies for the treatment of hearing loss
Y Ma, AK Wise, RK Shepherd, RT Richardson
Pharmacology & therapeutics 200, 190-209, 2019
Mandates: US Department of Defense, US National Institutes of Health, Australian …
Impedance changes in chronically implanted and stimulated cochlear implant electrodes
C Newbold, S Mergen, R Richardson, P Seligman, R Millard, R Cowan, ...
Cochlear implants international 15 (4), 191-199, 2014
Mandates: US National Institutes of Health
Changes in biphasic electrode impedance with protein adsorption and cell growth
C Newbold, R Richardson, R Millard, C Huang, D Milojevic, R Shepherd, ...
Journal of neural engineering 7 (5), 056011, 2010
Mandates: US National Institutes of Health
The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection
AK Wise, T Tu, PJ Atkinson, BO Flynn, BE Sgro, C Hume, SJ O’Leary, ...
Hearing research 278 (1-2), 69-76, 2011
Mandates: US National Institutes of Health, Royal National Institute for Deaf People, UK
Neurotrophin gene therapy for sustained neural preservation after deafness
PJ Atkinson, AK Wise, BO Flynn, BA Nayagam, CR Hume, SJ O’Leary, ...
PLoS One 7 (12), e52338, 2012
Mandates: US National Institutes of Health, Action on Hearing Loss, UK
Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation
H Eastwood, D Pinder, D James, A Chang, S Galloway, R Richardson, ...
Hearing research 259 (1-2), 24-30, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program